Robbert J.C. Slebos on Muck Rack

Robbert J.C. Slebos

As seen in: European Journal of Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Robbert J.C.

Contact Robbert J.C., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer

|
By Spaarne Gasthuis, Meike de Wit, Joyce Sanders, Robbert J.C. Slebos
| European Journal of Cancer
Highlights • CDX2 is a prognostic biomarker for patients with stage II and III colon cancer. • CDX2 testing by mass spectrometry outperformed routine immunohistochemistry. • Application of quantitative assays can improve clinical utility of biomarkers. Abstract Aim Better stratification of patients with stage II and stage III colon cancer for risk of recurrence is urgently needed.
Open in Who Shared Issue with article?
See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Robbert J.C.

Contact Robbert J.C., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified